ArticleInternational journal of ophthalmology2026
Impact of different treatment approaches on long-term refractive and visual outcomes in retinopathy of prematurity.
Article in International journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo evaluate the long-term refractive and visual outcomes in infants with retinopathy of prematurity (ROP) treated with intravitreal bevacizumab (IVB), laser photocoagulation (LPC), or combined IVB+LPC therapy, and to assess disease severity on refractive development over five years.
methodsThis retrospective cohort study analyzed data from infants diagnosed with ROP between 2013 and 2018. Patients were categorized into four groups: IVB (
resultsThe study included 152 patients (76 females). The mean birth weight was 1256.1±555.6 g, and the mean week of birth was 29.1±2.9wk. RROP infants had the highest SE, closest to emmetropia. The IVB+LPC group showed the most significant myopic shift compared to other groups (
conclusionRefractive outcomes vary more in Type 1 ROP than AROP. IVB+LPC results in greater myopia; LPC is associated with increased astigmatism. Individualized refractive follow-up is essential, particularly for Type 1 ROP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.